Physiological role of plasma and its components and the clinical implications of different methods of apheresis: A narrative review.
apheresis
double filtration plasmapheresis
immunoadsorption
plasma
plasma exchange
therapeutic plasmapheresis
viscosity
Journal
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
ISSN: 1744-9987
Titre abrégé: Ther Apher Dial
Pays: Australia
ID NLM: 101181252
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
revised:
17
06
2020
received:
02
05
2020
accepted:
22
07
2020
pubmed:
28
7
2020
medline:
12
11
2021
entrez:
26
7
2020
Statut:
ppublish
Résumé
Nowadays, therapeutic plasmapheresis (TP) is accepted as part of the treatment for specific groups of diseases. The availability of different methods, including double filtration and adsorption, increases selectivity for the removal of substances. However, the use of these techniques requires a thorough understanding of the characteristics and components of plasma. By considering pivotal papers from several databases, the aim of this narrative review is to describe the characteristics of plasma related to apheresis techniques. We have tried to cover the clinical implications including physiology, estimation of plasma volume, viscosity, and a description of its components including the size, volume of distribution, and half-lives of the different substances to be removed or maintained depending on the clinical situation and applied apheresis technique. Applying this knowledge will help us to choose the right method and dosage and improve the efficacy of the procedure by preventing or addressing any complications.
Identifiants
pubmed: 32710797
doi: 10.1111/1744-9987.13567
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
262-272Informations de copyright
© 2020 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.
Références
Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing Committee of the American Society for apheresis: The eighth special issue. J Clin Apher. 2019;34(3):171-354.
Kaplan AA. Therapeutic plasma exchange: Core curriculum 2008. Am J Kidney Dis. 2008;52(6):1180-1196.
Sanchez AP, Cunard R, Ward DM. The selective therapeutic apheresis procedures. J Clin Apher. 2013;28(1):20-29.
Hafer C, Golla P, Gericke M, et al. Membrane versus centrifuge-based therapeutic plasma exchange: A randomized prospective crossover study. Int Urol Nephrol. 2016;48(1):133-138.
Chauvel F, Reboul P, Cariou S, et al. Use of double filtration plasmapheresis for the treatment of acquired thrombocytopenic thrombotic purpura. Ther Apher Dial. 2020. https://doi.org/10.1111/1744-9987.13477.
Nakanishi T, Suzuki N, Kuragano T, Nagasawa Y, Hasuike Y. Current topics in therapeutic plasmapheresis. Clin Exp Nephrol. 2014;18(1):41-49.
Agishi T, Kaneko I, Hasuo Y, et al. Double filtration plasmapheresis. Trans Am Soc Artif Internal Organ. 1980;26:406-411.
Sueoka A. Therapeutic apheresis application using membrane plasma fractionation technology: Present scope and limitations. Ther Apher. 2000;4(3):211-212.
Bambauer R. Principles and technology of therapeutic plasma exchange. Klinische Anasthesiologie und Intensivtherapie. 1993;45:135-46. Prinzipien und Technologie des therapeutischen Plasmaaustauschs.
Jagdish K, Jacob S, Varughese S, et al. Effect of double filtration plasmapheresis on various plasma components and patient safety: a prospective observational cohort study. Ind J Nephrol. 2017;27(5):377-383.
Simmons P, Penny R, Goller I. Plasma proteins: a review. Med J Aust. 1969;2(10):494-506.
Mathew J, Sankar P, Varacallo M. Physiology, Blood Plasma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; April 25, 2020.
Greer JP, Arber DA, Glader B, List AF, Means RT. Wintrobe's clinical hematology. Philadelphia, PA: Wolters Kluwer Health, 2013.
International Committee for Standardization in Haematology. Recommended methods for measurement of red-cell and plasma volume. J Nucl Med. 1980;21(8):793-800.
Ismail N, Kiprov DD, Hakim RM. Plasmapheresis. In: Daugirdas JT, Blake PG, Ing TS, editors. Handbook of dialysis. Fourth ed. Philadelphia,PA: Lippincott Williams & Wilkins, 2007; p. 275-299.
Hakim RM. Plasmapheresis. In: Daugirdas JT, Blake PG, Ing TS, editors. Handbook of dialysis. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2001; p. 231-262.
Kaplan AA. A simple and accurate method for prescribing plasma exchange. ASAIO Trans. 1990;36(3):M597-M599.
Staley EM, Hoang ST, Liu H, Pham HP. A brief review of common mathematical calculations in therapeutic apheresis. J Clin Apher. 2019;34(5):607-612.
Lemmens HJ, Bernstein DP, Brodsky JB. Estimating blood volume in obese and morbidly obese patients. Obes Surg. 2006;16(6):773-776.
Kaplan AA. Therapeutic plasma exchange: A technical and operational review. J Clin Apher. 2013;28(1):3-10.
Williams ME, Balogun RA. Principles of separation: indications and therapeutic targets for plasma exchange. Clin J Am Soc Nephrol. 2014;9(1):181-190.
Cho YI, Cho DJ, Rosenson RS. Endothelial shear stress and blood viscosity in peripheral arterial disease. Curr Atheroscler Rep. 2014;16(4):404.
Nader E, Skinner S, Romana M, et al. Blood rheology: Key parameters, impact on blood flow, role in sickle cell disease and effects of exercise. Front Physiol. 2019;10:1329.
Kesmarky G, Kenyeres P, Rabai M, Toth K. Plasma viscosity: A forgotten variable. Clin Hemorheol Microcirc. 2008;39(1-4):243-246.
Dumas G, Merceron S, Zafrani L, et al. [Hyperviscosity syndrome]. La Revue de medecine interne. Syndrome d'hyperviscosite plasmatique. 2015;36(9):588-595.
Ascolese M, Farina A, Fasano A. The Fahraeus-Lindqvist effect in small blood vessels: How does it help the heart? J Biologic Phys. 2019;45(4):379-394.
Pfitzner J. Poiseuille and his law. Anaesthesia. 1976;31(2):273-275.
Mokken FC, Kedaria M, Henny CP, Hardeman MR, Gelb AW. The clinical importance of erythrocyte deformability, a hemorrheological parameter. Ann Hematol. 1992;64(3):113-122.
Lenz C, Rebel A, Waschke KF, Koehler RC, Frietsch T. Blood viscosity modulates tissue perfusion: Sometimes and somewhere. Transfus Alternat Transfus Med. 2008;9(4):265-272.
Gertz MA. Acute hyperviscosity: syndromes and management. Blood. 2018;132(13):1379-1385.
Kielstein JT, Hesse G, Bahr MJ, et al. Procedure-related pulmonary hypertension in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection-role of ethanol, hemolysis, asymmetric dimethylarginine, and the nitric oxide system. Crit Care Med. 2009;37(4):1483-1485.
Barnett CF, Hsue PY, Machado RF. Pulmonary hypertension: an increasingly recognized complication of hereditary hemolytic anemias and HIV infection. JAMA. 2008;299(3):324-331.
Bosch T, Wendler T, Jaeger BR, Samtleben W. Improvement of hemorheology by DALI apheresis: acute effects on plasma viscosity and erythrocyte aggregation in hypercholesterolemic patients. Ther Apher. 2001;5(5):372-376.
Crawford J, Cox EB, Cohen HJ. Evaluation of hyperviscosity in monoclonal gammopathies. Am J Med. 1985;79(1):13-22.
Metry G, Adhikarla R, Schneditz D, Ronco C, Levin NW. Effect of changes in the intravascular volume during hemodialysis on blood viscoelasticity. Ind J Nephrol. 2011;21(2):95-100.
Koss MJ, Kurz P, Tsobanelis T, et al. Prospective, randomized, controlled clinical study evaluating the efficacy of rheopheresis for dry age-related macular degeneration. Dry AMD treatment with Rheopheresis trial-ART. Graefe's Arch Clin Exper Ophthalmol. 2009;247(10):1297-1306.
Robert T, Lionet A, Bataille S, Seret G. Rheopheresis: a new therapeutic approach in severe calciphylaxis. Nephrol Ther. 2020;25(4):298-304.
Klingel R, Erdtracht B, Gauss V, Piazolo A, Mausfeld-Lafdhiya P, Diehm C. Rheopheresis in patients with critical limb ischemia-results of an open label prospective pilot trial. Ther Apher Dial. 2005;9(6):473-481.
Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome: etiologies, pathophysiology, and management. Kidney Int. 2017;92(1):37-46.
Yang F, Zhang Y, Liang H. Interactive association of drugs binding to human serum albumin. Int J Mol Sci. 2014;15(3):3580-3595.
Sarnatskaya VV, Yushko LA, Sakhno LA, et al. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients. Artif Cells Blood Substit Immobil Biotechnol. 2007;35(3):287-308.
Yu S, Schuchardt M, Tölle M, et al. Interaction of human serum albumin with uremic toxins: A thermodynamic study. RSC Adv. 2017;7(45):27913-27922.
Levitt DG, Levitt MD. Human serum albumin homeostasis: A new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med. 2016;9:229-255.
Gondouin B, Hutchison CA. High cut-off dialysis membranes: Current uses and future potential. Adv Chronic Kidney Dis. 2011;18(3):180-187.
Hanafusa N. Theoretical basis of pathogenic substance removal during plasmapheresis. Ther Apher Dial. 2011;15(5):421-430.
Kaplan AA. Moderator's view: high-volume plasma exchange: Pro, con and consensus. Nephrol Dial Transplant. 2017;32(9):1464-1467.
Hafer C, Kielstein JT. Pro: High dose of therapeutic plasma exchange-mind the gap. Nephrol Dial Transplant. 2017;32(9):1457-1460.
Szpirt W, Schwartz J. Con: high-volume plasma exchange application in nephrology and beyond. Nephrol Dial Transplant. 2017;32(9):1461-1463.
Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520.
Parker AR, Skold M, Ramsden DB, Ocejo-Vinyals JG, Lopez-Hoyos M, Harding S. The clinical utility of measuring IgG subclass immunoglobulins during immunological investigation for suspected primary antibody deficiencies. Lab Med. 2017;48(4):314-325.
Staudt A, Bohm M, Knebel F, et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation. 2002;106(19):2448-2453.
Valenzuela NM, Schaub S. The biology of IgG subclasses and their clinical relevance to transplantation. Transplantation. 2018;102(1S) Suppl 1:S7-S13.
Doberer K, Bond G, Klager J, et al. Immunoadsorption combined with membrane filtration to counteract early treatment-refractory antibody-mediated rejection. Blood Purif. 2020;1-10. https://doi.org/10.1159/000506504.
Ohkubo A, Okado T, Kurashima N, et al. Removal characteristics of immunoglobulin G subclasses by conventional plasma exchange and selective plasma exchange. Ther Apher Dial. 2015;19(4):361-366.
Yamada H, Itoh A, Hatanaka Y, Tsukiji M, Takamori K. Screening and analysis of adsorbents for pemphigus autoantibodies. Ther Apher Dial. 2010;14(3):292-297.
Reeves HM, Winters JL. The mechanisms of action of plasma exchange. Br J Haematol. 2014;164(3):342-351.
Mathern DR, Heeger PS. Molecules great and small: the complement system. Clin J Am Soc Nephrol. 2015;10(9):1636-1650.
Ricklin D, Reis ES, Lambris JD. Complement in disease: a defence system turning offensive. Nat Rev Nephrol. 2016;12(7):383-401.
Vieyra MB, Heeger PS. Novel aspects of complement in kidney injury. Kidney Int. 2010;77(6):495-499.
Dobo J, Kocsis A, Gal P. Be on target: Strategies of targeting alternative and lectin pathway components in complement-mediated diseases. Front Immunol. 2018;9:1851.
Raina R, Grewal MK, Radhakrishnan Y, et al. Optimal management of atypical hemolytic uremic disease: challenges and solutions. Int J Nephrol Renovasc Dis. 2019;12:183-204.
Fakhouri F, Zuber J, Fremeaux-Bacchi V, Loirat C. Haemolytic uraemic syndrome. Lancet. 2017;390(10095):681-696.
Kronbichler A. Therapeutic plasma exchange strategy in complement-mediated diseases: An overview. Ther Apher Dial. 2018;22(1):8-10.
Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J Anaesth. 2014;58(5):515-523.
Springer TA. Biology and physics of von Willebrand factor concatamers. J Thromb Haemostasis. 2011;9(Suppl 1):130-143.
Lippok S, Obser T, Muller JP, et al. Exponential size distribution of von Willebrand factor. Biophys J. 2013;105(5):1208-1216.
Valentijn KM, Eikenboom J. Weibel-Palade bodies: A window to von Willebrand disease. J Thromb Haemostasis. 2013;11(4):581-592.
Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood. 2015;125(13):2052-2061.
Zollner S, Pablik E, Druml W, Derfler K, Rees A, Biesenbach P. Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two. Blood Purif. 2014;38(2):160-166.
Lin SM, Yeh JH, Lee CC, Chiu HC. Clearance of fibrinogen and von Willebrand factor in serial double-filtration plasmapheresis. J Clin Apher. 2003;18(2):67-70.
Ohkubo A, Okado T, Miyamoto S, et al. Fibrinogen reduction during selective plasma exchange due to membrane fouling. Ther Apher Dial. 2017;21(3):232-237.
Marlu R, Malvezzi P, Seyve L, et al. Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation. Thromb Res. 2018;166:113-121.
Connelly-Smith L, Tanhehco YC, Chhibber V, et al. Choosing wisely for apheresis. J Clin Apher. 2018;33(5):576-579.
Tholking G, Mesters R, Dittrich R, Pavenstadt H, Kumpers P, Reuter S. Assessment of hemostasis after plasma exchange using rotational thrombelastometry (ROTEM). PloS one. 2015;10(6):e0130402.
Pusey CD, Levy JB. Plasmapheresis in immunologic renal disease. Blood Purif. 2012;33(1-3):190-198.
Lent-Schochet D, Jialal I. Biochemistry, lipoprotein metabolism. Treasure Island (FL): StatPearls, 2020.
Segrest JP, Jones MK, De Loof H, Dashti N. Structure of apolipoprotein B-100 in low density lipoproteins. J Lipid Res. 2001;42(9):1346-1367.
Julius U. Current role of lipoprotein apheresis in the treatment of high-risk patients. J Cardiovasc Develop Dis. 2018;5(2):27.
Schmaldienst S, Banyai S, Stulnig TM, et al. Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia. Atherosclerosis. 2000;151(2):493-499.
Jawi MM, Frohlich J, Chan SY. Lipoprotein(a) the insurgent: a new insight into the structure, function, metabolism, pathogenicity, and medications affecting lipoprotein(a) molecule. J Lipid. 2020;2020:3491764.
Wang A, Richhariya A, Gandra SR, et al. Systematic review of low-density lipoprotein cholesterol apheresis for the treatment of familial hypercholesterolemia. J Am Heart Assoc. 2016;5(7):e003294.
Koziolek MJ, Hennig U, Zapf A, et al. Retrospective analysis of long-term lipid apheresis at a single center. Ther Apher Dial. 2010;14(2):143-152.
Mellwig KP, Pulawski E, Horstkotte D, van Buuren F. Lipid apheresis: oxidative stress, rheology, and vasodilatation. Clin Res Cardiol Suppl. 2012;7:45-49.
Musambil M, Al-Rubeaan K, Al-Qasim S, Al Naqeb D, Al-Soghayer A. Primary hypertriglyceridemia: A look back on the clinical classification and genetics of the disease. Curr Diabetes Rev. 2020;16(6):521-531.
Ewald N, Kloer HU. Severe hypertriglyceridemia: an indication for apheresis? Atheroscler Suppl. 2009;10(5):49-52.
Scriver CR, Lamm P, Clow CL. Plasma amino acids: Screening, quantitation, and interpretation. Am J Clin Nutr. 1971;24(7):876-890.
Hiemstra TF, Casian A, Boraks P, Jayne DR, Schoenmakers I. Plasma exchange induces vitamin D deficiency. QJM. 2014;107(2):123-130.
Reddi A, Frank O, DeAngelis B, et al. Vitamin status in patients undergoing single or multiple plasmapheresis. J Am Coll Nutr. 1987;6(6):485-489.
Compton F, Salazar E, Klein K, Tint H, Castillo B, Bai Y. New onset iron deficiency anemia in chronic therapeutic plasma exchange patients. Ann Clin Lab Sci. 2018;48(3):273-278.